The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Documentation of awarded credit is provided for participants in exchange for completed activity…
Coinciding with Earth Day, a new paper tackles how imagers can improve sustainability, while preparing for environmental crises.
Prominent trialists took issue with the primary endpoint, how it was powered, and what effect COVID-19 and Katsanos played.
Julia Colombijn, MSc, highlights the systematic underrepresentation of CKD patients in cardiovascular clinical trials.
Frequent bathroom breaks and setting timers to remind you to stand up can nudge people in the right direction, says Carl Lavie.
Adverse pregnancy outcomes, though often overlooked by busy clinicians, should spur early prevention and close attention.
Hear some hot takes on REDUCE-AMI, ORBITA-COSMIC, PREVENT, and more of the top news this month.
Beyond step count, other measures like cadence and exercise capacity could detect an early signal before symptoms develop.
Initiated by Abbott/Thoratec and deemed Class I by the FDA, the recall is a response to reports of 273 injuries and 14 deaths.
The study of VA patients suggests that starting a new BP drug increases the risk of falls and fractures, likely due to hypotension.
With a 19% increase in new HF, vaping isn’t as safe as many patients may perceive it to be, researchers say.
